0001062993-13-004735.txt : 20130919 0001062993-13-004735.hdr.sgml : 20130919 20130919190724 ACCESSION NUMBER: 0001062993-13-004735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130917 FILED AS OF DATE: 20130919 DATE AS OF CHANGE: 20130919 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOULD GEORGE M CENTRAL INDEX KEY: 0001242115 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 131106419 MAIL ADDRESS: STREET 1: C/O PROTINE DESIGN LAB STREET 2: 34801 CAMPUS DR CITY: FREEMONT STATE: CA ZIP: 94555 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2013-09-17 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001242115 GOULD GEORGE M 287 TILLOU ROAD SOUTH ORANGE NJ 07079 1 0 0 0 Stock Option (Right to Buy) 17.91 2013-09-17 4 A 0 15000 0 A 2023-09-17 Common Stock 15000 15000 D The options were granted on September 17, 2013 and will vest in four equal annual installments beginning on the first anniversary of the grant date. /s/ George Gould by Carl A. Valenstein, attorney in fact 2013-09-19